A PRELIMINARY STUDY OF P-5227, a new active tricyclic antipsychotic agent.
D000328:Adult; D001519:Behavior / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002986:Clinical Trials as Topic; D005116:Extrapyramidal Tracts / Q000187:drug effects; D006801:Humans; D008111:Liver Function Tests; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D011674:Pulse / Q000187:drug effects; D012559:Schizophrenia / Q000188:drug therapy*; D012890:Sleep / Q000187:drug effects; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D010879:Piperazines; D014149:Tranquilizing Agents